rs185533973

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001379110.1(SLC9A6):​c.1460+10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000525 in 1,187,672 control chromosomes in the GnomAD database, including 11 homozygotes. There are 192 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00026 ( 1 hom., 10 hem., cov: 23)
Exomes 𝑓: 0.00055 ( 10 hom. 182 hem. )

Consequence

SLC9A6
NM_001379110.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.576

Publications

0 publications found
Variant links:
Genes affected
SLC9A6 (HGNC:11079): (solute carrier family 9 member A6) This gene encodes a sodium-hydrogen exchanger that is amember of the solute carrier family 9. The encoded protein localizes to early and recycling endosomes and may be involved in regulating endosomal pH and volume. Defects in this gene are associated with X-linked syndromic cognitive disability, Christianson type. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
SLC9A6 Gene-Disease associations (from GenCC):
  • Christianson syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-136024493-A-G is Benign according to our data. Variant chrX-136024493-A-G is described in ClinVar as [Benign]. Clinvar id is 139204.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000259 (29/111910) while in subpopulation EAS AF = 0.00785 (28/3569). AF 95% confidence interval is 0.00558. There are 1 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC9A6NM_001379110.1 linkc.1460+10A>G intron_variant Intron 13 of 17 ENST00000630721.3 NP_001366039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC9A6ENST00000630721.3 linkc.1460+10A>G intron_variant Intron 13 of 17 4 NM_001379110.1 ENSP00000487486.2 A0A0D9SGH0
SLC9A6ENST00000370695.8 linkc.1616+10A>G intron_variant Intron 12 of 15 1 ENSP00000359729.4 Q92581-2
SLC9A6ENST00000370698.7 linkc.1520+10A>G intron_variant Intron 12 of 15 1 ENSP00000359732.3 Q92581-1
SLC9A6ENST00000370701.6 linkc.1460+10A>G intron_variant Intron 13 of 16 1 ENSP00000359735.1 Q92581-3

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
28
AN:
111858
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00754
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000662
GnomAD2 exomes
AF:
0.000279
AC:
51
AN:
182746
AF XY:
0.000253
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00368
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000552
AC:
594
AN:
1075762
Hom.:
10
Cov.:
27
AF XY:
0.000531
AC XY:
182
AN XY:
342482
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26016
American (AMR)
AF:
0.00
AC:
0
AN:
35063
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19222
East Asian (EAS)
AF:
0.0195
AC:
586
AN:
30101
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53425
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40511
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4067
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
821989
Other (OTH)
AF:
0.000176
AC:
8
AN:
45368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000259
AC:
29
AN:
111910
Hom.:
1
Cov.:
23
AF XY:
0.000293
AC XY:
10
AN XY:
34074
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30868
American (AMR)
AF:
0.00
AC:
0
AN:
10487
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00785
AC:
28
AN:
3569
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2670
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5985
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53249
Other (OTH)
AF:
0.000654
AC:
1
AN:
1529
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.000147

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Christianson syndrome Benign:2
May 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 14, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 13, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.9
DANN
Benign
0.54
PhyloP100
0.58
PromoterAI
-0.0056
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs185533973; hg19: chrX-135106652; API